All Outputs (2)

Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia—a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial (2024)
Journal Article
Flett, L., Abdelatif, R., Akhtar Baz, S., Brady, S., Corbacho, B., Common, K., …Barlow, G. (2024). Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia—a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial. Trials, 25, Article 427. https://doi.org/10.1186/s13063-024-08272-w

Background Acute leukaemias (AL) are life-threatening blood cancers that can be potentially cured with treatment involving myelosuppressive, multiagent, intensive chemotherapy (IC). However, such treatment is associated with a risk of serious infecti... Read More about Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia—a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial.

What really is nontokenistic fully inclusive patient and public involvement/engagement in research? (2024)
Journal Article
Hilton, A., Megson, M., Aryankhesal, A., Blake, J., Rook, G., Irvine, A., …TIMES programme team. (2024). What really is nontokenistic fully inclusive patient and public involvement/engagement in research?. Health Expectations, 27(2), Article e14012. https://doi.org/10.1111/hex.14012

Patient and public involvement and engagement (PPIE) is critically important in healthcare research. A useful starting point for researchers to understand the scope of PPIE is to review the definition from the National Institute for Health and Care R... Read More about What really is nontokenistic fully inclusive patient and public involvement/engagement in research?.